The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
about
Drug delivery and formulations for the topical treatment of psoriasis.Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery.Psoriasis (chronic plaque)Systemic methotrexate therapy for psoriasis: past, present and future.Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies.Recommendations for the topical treatment of psoriasis.Psoriasis: consensus on topical therapies.Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis.Topical delivery for the treatment of psoriasis.Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going?Combination therapy in psoriasis: an evidence-based review.Biologic therapy with or without topical treatment in psoriasis: what does the current evidence say?Beyond monotherapy: a systematic review on creative strategies in topical therapy of psoriasis.The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial).Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Effects of maxacalcitol ointment on skin lesions in patients with psoriasis receiving treatment with adalimumab.EfalizumabTransition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)
P2860
Q33318104-32EC3E01-32BD-48BE-8B03-0B857C06BC58Q33544410-CF1768C7-0F99-4517-AD7E-507D65A4D832Q34010557-B50C701A-2B8B-4B55-B9C0-FFCF02DFBA82Q34356265-CFBD7363-64A6-43F9-9C0B-62110C3311FAQ34434044-0841594C-CEC6-4447-AC10-455399F12E00Q36178774-1409EDB7-50A5-4B55-B9C5-2D7224F42231Q37032806-3C739E56-6DC3-4B7A-A533-FF0154D237FDQ37465349-364395B1-9663-40F3-86F0-FB4156F37522Q37774344-EBCB7F32-9E75-48D0-B49F-4D1B7CFFB627Q37959978-9C4E42CA-163B-4F85-9C27-A989E315B6D1Q38074846-74104A5E-9BC5-48C8-8EC9-984864BAB377Q38229869-1FBD276F-CFD2-48FF-8E97-B5479B140887Q39290746-02AED604-57EA-4138-ACD4-4870D96E1847Q45221388-784FB3D0-070C-4EBE-A47F-8AB351F61E8BQ47260366-39933320-4092-4216-BA19-2A4133EB974FQ51621271-FA09ED62-D310-4561-8D12-CB98785F9F8FQ58434864-6E6A0834-AD7F-4296-B345-E4996A8ECE8EQ58639485-FF91DFFD-26DD-4DCB-9522-835DCFC41A12
P2860
The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The combination of calcipotrio ...... o-controlled randomized trial.
@en
The combination of calcipotrio ...... o-controlled randomized trial.
@nl
type
label
The combination of calcipotrio ...... o-controlled randomized trial.
@en
The combination of calcipotrio ...... o-controlled randomized trial.
@nl
prefLabel
The combination of calcipotrio ...... o-controlled randomized trial.
@en
The combination of calcipotrio ...... o-controlled randomized trial.
@nl
P2093
P1476
The combination of calcipotrio ...... o-controlled randomized trial.
@en
P2093
De La Brassine M
Guilhou JJ
Lauharanta J
Ostrojic A
P2860
P304
P356
10.1046/J.1365-2133.2003.05173.X
P407
P577
2003-02-01T00:00:00Z